Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis
TL Cherpes, LA Meyn, MA Krohn… - Clinical infectious …, 2003 - academic.oup.com
TL Cherpes, LA Meyn, MA Krohn, JG Lurie, SL Hillier
Clinical infectious diseases, 2003•academic.oup.comA longitudinal cohort study of sexually active women 18–30 years of age was conducted to
identify variables associated with the acquisition of herpes simplex virus type 2 (HSV-2)
infections. Six hundred seventy HSV-2–seronegative women were followed up at 4-month
intervals for 1 year; acquisition of HSV-2 antibodies was detected in 32 of these women.
Black race,⩽ 12 years of education, having a new sex partner, and bacterial vaginosis (BV)
were associated with HSV-2 seroconversion on univariate analysis. Antecedent HSV-1 …
identify variables associated with the acquisition of herpes simplex virus type 2 (HSV-2)
infections. Six hundred seventy HSV-2–seronegative women were followed up at 4-month
intervals for 1 year; acquisition of HSV-2 antibodies was detected in 32 of these women.
Black race,⩽ 12 years of education, having a new sex partner, and bacterial vaginosis (BV)
were associated with HSV-2 seroconversion on univariate analysis. Antecedent HSV-1 …
Abstract
A longitudinal cohort study of sexually active women 18–30 years of age was conducted to identify variables associated with the acquisition of herpes simplex virus type 2 (HSV-2) infections. Six hundred seventy HSV-2–seronegative women were followed up at 4-month intervals for 1 year; acquisition of HSV-2 antibodies was detected in 32 of these women. Black race, ⩽12 years of education, having a new sex partner, and bacterial vaginosis (BV) were associated with HSV-2 seroconversion on univariate analysis. Antecedent HSV-1 infection was not protective against HSV-2 acquisition. After controlling for other identified risk factors in multivariable models, the diagnosis of BV remained associated with an increased risk of acquiring HSV-2 infection (hazard ratio, 2.1; 95% confidence interval, 1.0–4.5; P = .05). In this study, the population attributable risk of BV for HSV-2 seroconversion was 21%. Additional studies are needed to determine whether screening and treatment of BV could reduce susceptibility to the acquisition of HSV-2 in women.
Oxford University Press